During the hearing, when asked by Dutch politician Ross if the Pfizer COVID vaccine was tested on stopping the transmission of the virus before it entered the market, Janine Small responded while smiling, “Regarding the question around did we know about stopping immunization before it entered the market? No. We have to really move at the speed of science to really understand what is taking place in the market.”

This statement was confirmed by an unredacted Pfizer agreement from a FOIA request with the Slovenian government. Here is a little snippet that indicates that Pfizer is evolving each component of the “vaccine”, presumably advising all deviations from clinical trial dosages and regimens to each EU member state (and every other country that has taken Pfizer injections).

“The Participating Member State acknowledges that the Vaccine and materials related to the Vaccine, and their components and constituent materials are being rapidly developed due to the emergency circumstances of the COVID-19 pandemic and will continue to be studied after provision of the Vaccine to the Participating Member States under the APA,” according to the documents.

“The Participating Member State further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects from the Vaccine that are not currently known.” Reports from the Vaccine Adverse Events Reporting System (VAERS) including non-domestic reports showed there are now over 1.4 million cases of COVID-19 vaccine adverse reactions including more than 32,828 deaths through December 9, 2022.

After two years, FDA finally admitted Pfizer’s COVID-19 vaccine had been linked to blood clotting in older individuals based on the result of one of the largest studies of elderly persons aged 65 years and above. The new study states that the FDA “strongly believes the potential benefits of COVID-19 vaccination outweigh the potential risks of COVID-19 infection.” No evidence was cited in support of the belief.